200 related articles for article (PubMed ID: 23357550)
1. All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Zhang Q; Kline DE; Bhattacharya S; Crawford RB; Conolly RB; Thomas RS; Andersen ME; Kaminski NE
Toxicol Appl Pharmacol; 2013 Apr; 268(1):17-26. PubMed ID: 23357550
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Bach2 by the aryl hydrocarbon receptor as a mechanism for suppression of B-cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
De Abrew KN; Phadnis AS; Crawford RB; Kaminski NE; Thomas RS
Toxicol Appl Pharmacol; 2011 Apr; 252(2):150-8. PubMed ID: 21296099
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.
Schneider D; Manzan MA; Yoo BS; Crawford RB; Kaminski N
Toxicol Sci; 2009 Apr; 108(2):377-88. PubMed ID: 19237549
[TBL] [Abstract][Full Text] [Related]
4. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.
Schneider D; Manzan MA; Crawford RB; Chen W; Kaminski NE
J Pharmacol Exp Ther; 2008 Aug; 326(2):463-74. PubMed ID: 18483191
[TBL] [Abstract][Full Text] [Related]
5. Stochastic modeling of B lymphocyte terminal differentiation and its suppression by dioxin.
Zhang Q; Bhattacharya S; Kline DE; Crawford RB; Conolly RB; Thomas RS; Kaminski NE; Andersen ME
BMC Syst Biol; 2010 Apr; 4():40. PubMed ID: 20359356
[TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
Sulentic CE; Holsapple MP; Kaminski NE
Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells.
Suh J; Jeon YJ; Kim HM; Kang JS; Kaminski NE; Yang KH
Toxicol Appl Pharmacol; 2002 Jun; 181(2):116-23. PubMed ID: 12051995
[TBL] [Abstract][Full Text] [Related]
8. Induction of the aryl hydrocarbon receptor-responsive genes and modulation of the immunoglobulin M response by 2,3,7,8-tetrachlorodibenzo-p-dioxin in primary human B cells.
Lu H; Crawford RB; Suarez-Martinez JE; Kaplan BL; Kaminski NE
Toxicol Sci; 2010 Nov; 118(1):86-97. PubMed ID: 20702590
[TBL] [Abstract][Full Text] [Related]
9. An integrated genomic analysis of aryl hydrocarbon receptor-mediated inhibition of B-cell differentiation.
De Abrew KN; Kaminski NE; Thomas RS
Toxicol Sci; 2010 Dec; 118(2):454-69. PubMed ID: 20819909
[TBL] [Abstract][Full Text] [Related]
10. A bistable switch underlying B-cell differentiation and its disruption by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Bhattacharya S; Conolly RB; Kaminski NE; Thomas RS; Andersen ME; Zhang Q
Toxicol Sci; 2010 May; 115(1):51-65. PubMed ID: 20123757
[TBL] [Abstract][Full Text] [Related]
11. Developmental exposure to 2,3,7,8 tetrachlorodibenzo-p-dioxin attenuates capacity of hematopoietic stem cells to undergo lymphocyte differentiation.
Ahrenhoerster LS; Tate ER; Lakatos PA; Wang X; Laiosa MD
Toxicol Appl Pharmacol; 2014 Jun; 277(2):172-82. PubMed ID: 24709672
[TBL] [Abstract][Full Text] [Related]
12. Role of aryl hydrocarbon receptor polymorphisms on TCDD-mediated CYP1B1 induction and IgM suppression by human B cells.
Kovalova N; Manzan M; Crawford R; Kaminski N
Toxicol Appl Pharmacol; 2016 Oct; 309():15-23. PubMed ID: 27535091
[TBL] [Abstract][Full Text] [Related]
13. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway.
Sulentic CE; Holsapple MP; Kaminski NE
J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109
[TBL] [Abstract][Full Text] [Related]
14. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.
Phadnis-Moghe AS; Crawford RB; Kaminski NE
Toxicol Sci; 2015 Mar; 144(1):39-50. PubMed ID: 25543051
[TBL] [Abstract][Full Text] [Related]
15. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation of Pax5 in lipopolysaccharide-activated B cells.
Yoo BS; Boverhof DR; Shnaider D; Crawford RB; Zacharewski TR; Kaminski NE
Toxicol Sci; 2004 Feb; 77(2):272-9. PubMed ID: 14600275
[TBL] [Abstract][Full Text] [Related]
16. Aryl hydrocarbon receptor activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs human B lymphopoiesis.
Li J; Phadnis-Moghe AS; Crawford RB; Kaminski NE
Toxicology; 2017 Mar; 378():17-24. PubMed ID: 28049042
[TBL] [Abstract][Full Text] [Related]
17. 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation.
North CM; Crawford RB; Lu H; Kaminski NE
Toxicol Sci; 2010 Jul; 116(1):99-112. PubMed ID: 20348231
[TBL] [Abstract][Full Text] [Related]
18. Suppression of the IgM Response by Aryl Hydrocarbon Receptor Activation in Human Primary B Cells Involves Impairment of Immunoglobulin Secretory Processes.
Zhou J; Henriquez J; Crawford R; Kaminski N
Toxicol Sci; 2018 May; 163(1):319-329. PubMed ID: 29462421
[TBL] [Abstract][Full Text] [Related]
19. Immunological characterization of the aryl hydrocarbon receptor (AHR) knockout rat in the presence and absence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Phadnis-Moghe AS; Chen W; Li J; Crawford RB; Bach A; D'Ingillo S; Kovalova N; Suarez-Martinez JE; Kaplan BL; Harrill JA; Budinsky R; Rowlands JC; Thomas RS; Kaminski NE
Toxicology; 2016 Aug; 368-369():172-182. PubMed ID: 27590929
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of TCDD-induced AhR-mediated gene expression in human, mouse and rat primary B cells.
Kovalova N; Nault R; Crawford R; Zacharewski TR; Kaminski NE
Toxicol Appl Pharmacol; 2017 Feb; 316():95-106. PubMed ID: 27913140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
